Skip to content

Altered gut microbiome composition in Parkinson's disease after ketogenic diet

Altered gut microbiome composition in Parkinson's disease after ketogenic diet

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045245
Enrollment
Unknown
Registered
2021-04-09
Start date
2021-04-20
Completion date
Unknown
Last updated
2021-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

The ketogenic diet group: ketogenic diet

Sponsors

The Fourth Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. According to the clinical diagnostic criteria of PD published by the Movement Disorders Association in 2015, clinically confirmed patients with primary Parkinson's disease; 2. No digestive system diseases, such as inflammatory enteritis, liver, gallbladder and pancreatic diseases;No digestive system stones and surgery; 3. Not taking any antibiotics in the last 3 months; 4. No diabetes and autoimmune diseases; 5. No familial aggregation of Parkinson's disease.

Exclusion criteria

Exclusion criteria: 1. All subjects were excluded from familial Parkinson's disease, Parkinson's superimposed syndrome, and secondary Parkinson's syndrome induced by cerebrovascular disease and poisoning. 2. In addition, subjects in both groups should exclude the following conditions: (1) Drugs and drugs: any drugs and drugs abuse, any regular use in the past 2 months (> 2 times) the following drugs: opioids, lopebutamine, inhaled beta-blockers or anticholinergics, glucocorticoids (oral or extraenteral), tricyclic antidepressants, antihistamines and anticholinergics (except for signs of PD), metoclopramide, cholinergics, doperidone, and proton pump inhibitors; (2) Organ failure: heart failure (excluding: cardiac function grade <= 2), known severe renal insufficiency (glomerular filtration rate < 30ml/min); (3) Other: B vitamin deficiency, serious uterine prolapse, peritonitis, the history of severe endometriosis, polyneuropathy, polio, symptomatic peripheral atherosclerosis (e.g., claudication), aortic aneurysm or dissection, lungs, or skin cancer, stomach, intestines, or urogenital fistula, any of the following happened 2 month before : one of severe hypokalemia or hyperkalemia requiring hospitalization, coma or gastrointestinal endoscopy, abdominal trauma.

Design outcomes

Primary

MeasureTime frame
Parkinson's disease related scale;Changes in intestinal flora;Changes in inflammatory cytokines;

Countries

China

Contacts

Public ContactChi Chunling

The Fourth Affiliated Hospital of Harbin Medical University

2532353212@163.com+86 15124528409

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026